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The accurate diagnosis of acute graft-versus-host disease following liver transplantation (LTx-aGVHD) has been hampered.
Chimerism appears in the majority of recipients after LT and its signiﬁcance in the diagnosis of LTx-aGVHD has not been clearly
established.To demonstratethesigniﬁcanceofchimerismon thediagnosisof LTx-aGVHD, we compared the change of chimerism
in syngeneic LT recipients, semiallogeneic LT recipients, and LTx-aGVHD induced recipients. Chimerism in PBMCs following
sex-mismatched LT wasidentiﬁed by real-time PCR based on a rat Y-chromosome-speciﬁcprimer. All recipients in semiallogeneic
group grew in a normal pattern. However, when 4 × 108 donor splenocytes were transferred simultaneously during LT, the
morbidity of lethal aGVHD was 100%. The chimerism appeared slightly higher in the semiallogeneic group than in the syngeneic
LT group, but the diﬀerence was not signiﬁcant.However, when the recipients developed lethal aGVHD after LT, chimerism in the
PBMCs increased progressively, and even at an early time, a signiﬁcant increase in chimerism was observed. In conclusion, high
level chimerism correlated well with LTx-aGVHD, and detection of chimerism soon after transplantation may be of value in the
diagnosis of LTx-aGVHD prior to the onset of symptoms.
1.Introduction
Acute graft-versus-host disease (aGVHD) is an uncommon
but devastating complication that occurs in 1-2% of recip-
ients after liver transplantation (LTx-aGVHD) in clinical
course [1]. LTx-aGVHD symptoms usually appear 2 to 6
weeks after transplantation and are characterized by fever,
skin rash, diarrhea, and pancytopenia. These symptoms may
initially be diﬃcult to diﬀerentiate from cytomegalovirus
disease or drug-induced rash and pancytopenia. The accu-
rate diagnosis of LTx-aGVHD has been hampered due to
the lack of a sensitive and speciﬁc diagnostic test, and
misdiagnosis may incur delayed treatment and diminish the
chance of patient survival. Previous studies showed that the
underdiagnosis of LTx-aGVHD is responsible for patients’
mortality rates to be as high as 85% [2–4]. In our center,
the liver transplantation program was established in 1993.
We have identiﬁed 3 patients with LTx-aGVHD, and all died
from infection, alimentary tract bleeding, or multiple organ
failure [5].
Since LTx-aGVHD results from the engraftment of T
lymphocytes associated with the liver graft, the demonstra-
tion of substantial donor T-lymphocyte chimerism may be
of value in the diagnosis of this disease [6–17]. However,
chimerism appears only transiently in the majority of
patients in the early postoperative period after liver trans-
plantation [18–22], and its signiﬁcance in the diagnosis of
LTx-aGVHD has not been clearly established. Furthermore,
it is unknown whether macrochimerism commonlyprecedes
symptomatic aGVHD.
In this study, we investigate the level of chimerism in the
peripheral blood that indicates the abnormal engraftment
of donor lymphocytes in our previously established rat
model with acute graft-versus-host disease following liver
transplantation [23, 24] and found that this is an eﬀective
and senitive method in the early diagnosis of LTx-aGVHD.2 International Journal of Hepatology
2.Materialsand Methods
2.1. Animals. Male Lewis (RT11) rats weighing 200–300g
were used as donors. Female Lewis and (Lewis
￿xBN
￿)F1
(RT11/n) rats of the same weight were used as recipients.
Animals were purchased from Beijing Vital River Company.
Both donors and recipients were housed in an animal
facility under speciﬁc pathogen-free conditions and received
humane care according to the National Institutes of Health
guidelines. All surgical procedures were conducted under
anesthesia using clean surgical instruments.
2.2. Liver Transplantation and Separation of Viable Spleno-
cytes. Orthotopic liver transplantation was performed using
the technique described by Kamada and Calne without the
anastomosis of the hepatic artery [25]. The animals were
allowed to recover in the operating suite, with free access to
standard food and water. No antibiotic agents were used.
Viable splenocytes were separated using a slightly mod-
iﬁed technique described by Kimura et al. [26]. Brieﬂy,
spleens from Lewis rats were minced and passed through
200-mesh stainless steel ﬁlters with 20 volumes of ice-cold
RPMI-1640. Erythrocytes were removed by hypotonic lysis
with sterile distilledwater. The suspension wascentrifuged at
300 × gf or10m in ut esat4 ◦C.Splenocyteswere resuspended
in RPMI-1640, checked for viability by trypan blue dye ex-
clusion, and counted.
2.3. LTx-aGVHD Induction and Animal Grouping.
(LewisXBN)F1recipientswere injected with freshly prepared
Lewis splenocytes via the femoral vein within 30 minutes
from liver transplantation. Rats were divided as follows into
four subgroups based on the numbers of splenocytes trans-
ferred. Group 1, syngeneic liver transplantation: Lewis rats
received liver graft from the same strain without splenocyte
transfusion. Group 2, semiallogeneic liver transplantation
without splenocyte transfusion: liver transplantation was
performed between Lewis rat (donor) and (LewisxBN)F1
rat (recipient) without splenocyte transfusion. Group 3,
semiallogeneic liver transplantation with the transfusion of
2 × 108 splenocytes: liver transplantation was performed
betweenLewisrat(donor)and(LewisxBN)F1rat(recipient).
Lewis splenocytes were adoptively transferred to the same
recipient immediately after liver transplantation. Group 4,
semiallogeneic liver transplantation with the transfusion of
4 × 108 splenocytes: liver transplantation was performed
betweenLewisrat(donor)and(LewisxBN)F1rat(recipient).
Lewis splenocytes were adoptively transferred to the same
recipient immediately after liver transplantation. Six rats in
each group were used to monitor survival over 100 days.
Peripheral blood was obtained every 4 days for 20 days
after transplantation from six rats in groups 1, 2, and 4 and
twelve rats in group 3. Recipient rats that developedaGVHD
were sacriﬁced on day 16 for tissue sampling. Peripheral
blood was obtained on day 50 from recipients that survived
without developing aGVHD, and these rats were sacriﬁced
on day 100 for tissue sampling.
2.4. Assessment of aGVHD. (1) Clinical course and animal
survival. All animals were observed twice a day for typical
aGVHD-related signs such as dermatitis, alopecia, weight
loss, diarrhea, hunched posture, and cachexia [27]. The
actuarialsurvivalrateandmeantimetodeath(meansurvival
time, MST) were calculated after observation for 100 days.
(2) Morphometric and histopathologic investigations.
Tissue samples were taken at the time of death. Skin, small
intestine, colon, and liver were pathologically evaluated.
Each sample was ﬁxed in 10% buﬀered neutral formalin,
embedded in paraﬃn, and cut into 5µm thick sections,
which were stained with hematoxylin-eosin (H&E). Slides
were coded without reference to groups and examined in a
blinded fashion by a pathologist. Abnormalities associated
with aGVHD were observed [28, 29].
2.5. Real-Time PCR Analysis of Chimerism in Peripheral
Blood Mononuclear Cells (PBMCs). The level of chimerism
in PBMCs after transplantation was determined using real-
time PCR. Blood samples were collected in heparinized
test tubes and were processed for analysis within 2 hours.
PBMCswere isolatedbydensity-gradientcentrifugationover
Ficoll-Hypaque (Shanghai Hengxin Chemical Reagent Co.
Ltd., China). Genomic DNA was isolated from PBMCs by
QIAamp DNA Mini Kit and QIAamp DNA Blood Mini
Kit (Qiagen, Valencia, Calif, USA). All pairs of primers for
real-time quantitative PCR were designed using the web-
based program Primer 3 (http://frodo.wi.mit.edu/primer3/).
Primers for SRY gene (forward primer 5 -CGAAGGGTT-
AAAGTGCCACAG-3 , reverse primer 5 -GTTCTTGGA-
GGACTGGTGTGC-3 , product of 150bp) were designed to
amplify all six SRY genes (SRY1, SRY2, SRY3, SRY3B, SRY3C,
and SRY3bI) in order to increase the sensitivity of detection
of male DNA. The total amount of rat genomic DNA or
male genomic DNA was determined using the absolute
quantiﬁcation program of SDS2.0 software on an ABI7900
machine (Applied Biosystems, Foster City, Calif, USA). A
series of dilutions of male rat genomic DNA (0.1ng/µL,
0.5ng/µL, 2.5ng/µL, 12.5ng/µL, and 50ng/µL) were used to
construct standard curves. 5HTT primers (forward primer
5 -TCCGCATGAATGCTGTGTAAC-3 , reverse primer 5 -
TTGGCTTAGAGGGGAGGAGTC-3, product of 102bp)
were used to quantitate total genomic DNA, and SRY
primers were used to quantitate male genomic DNA, and
the percentage of male genomic DNA was determined by
dividing the quantity of male genomic DNA by the total
genomic DNA. Each real-time PCR reaction included 1×
QuantiTect SYBR Green PCR Master Mix (Qiagen), 0.3µM
of each primer, and 2µL of sample DNA or serially diluted
standard male genomic DNA. The PCR program was 95◦C
for 15 minutes, 40 cycles of 94◦C for 15 seconds, 57◦Cf o r3 0
seconds, and 72◦C for 30 seconds.
2.6. Statistical Analysis. Data are presented as mean values ±
standard deviations. Survival analysis and intergroup com-
parisons were performed using ANOVA followed by the
least-signiﬁcant diﬀerence (LSD) or Bonferroni/Dunn Test,International Journal of Hepatology 3
which compensated for unequal group size. P<. 05 was
considered statistically signiﬁcant.
3.Results
3.1. The Morbidity of aGVHD and Animal Survival. The
morbidity of aGVHD in diﬀerent groups following liver
transplantation is summarized in Table 1.I ng r o u p2 ,t h e
(LewisXBN)F1 recipients that had received semiallogeneic
liver transplantation without splenocyte transfusion all sur-
vived >100 days without any evidence of aGVHD, as did the
animals in group1, which received syngeneic liver transplan-
tation. In groups 3 and 4, which received a splenocyte trans-
fusion inadditiontolivertransplantation, thesurvival ofrats
diminished depending on the number of donor splenocytes
transferred. In group 3, which received a transfusion of 2 ×
108 splenocytes, lethal aGVHD occurred in three recipients
(50%), the whereas administration of 4 × 108 splenocytes to
group 4 led to an aGVHD morbidity rate of 100% (6/6). No
sublethal aGVHD was observed in these groups.
3.2. The Clinical Course and Pathological Findings of aGVHD
Cxmfzy. After liver transplantation, all recipients had weight
loss due to operative wound. In groups 1 and 2, the weight
returnedtothepretransplantationlevelsgradually.Whenthe
recipients developed aGVHD in group 4, they lost weight
progressively (Figure 1). In group 2, the appearance of the
recipientsreturnedtonormalgraduallyafterthetransplanta-
tion(Figure 2(a)). The clinical course ofaGVHD was similar
ingroups3and4.Whena(LewisxBN)F1recipientdeveloped
aGVHD, the ﬁrst clinical signs of aGVHD appeared between
days 7 and 10, manifested as severe dermatitis occurring pre-
dominantly on the ears, foot pads, and genitalia, then diﬀuse
alopecia appeared. In the terminal stage of this disease, the
rats suﬀered from diarrhea became increasingly cachectic,
and exhibited a typical hunched posture (Figure 2(b))t h a t
culminated in death from 19 to 33days after transplantation.
Tissue samples were harvested at the time of death
f r o mt h e( L e w i s x B N ) F 1r e c i p i e n t si ng r o u p s3a n d4t h a t
developed aGVHD and also from separate groups sacriﬁced
16 days after transplantation. The histologic examination of
skin, intestineas and liver was normal in group 2 (Figure 3-
A1, B1, C1). In recipients that developed aGVHD in groups
3 and 4, the histologic examination of skin and intestine
showed characteristic pathologic features. The epidermis
and dermis in the skin were inﬁltrated by mononuclear
cells. Basilar degeneration and necrosis of keratinocytes
were also present (Figure 3-A2). The intestine contained
villous atrophy and lymphocytic inﬁltrates (Figure 3-B2).
Animals from the semiallogeneic group had normal liver
grafts without obvious mononuclear inﬁltrate within portal
tracts and sinusoids (Figure 3-C2).
3.3. Chimerism in Recipients after Syngeneic Liver Transplan-
tation and Semiallogeneic Liver Transplantation. The ratio of
donor to recipient PBMCs after syngeneic liver transplanta-
tion (group 1) was 1.4% ± 0.3%, 0.56% ± 0.20%, 0.37% ±
0.13%, 0.18% ± 0.07%, and 0.02% ± 0.02% on the 4th, 8th,
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Figure 1: Postoperative body weight curves following liver trans-
plantation. In group 1 and 2, all recipients lost body weight shortly
after transplantation but regained weight and grew well thereafter.
When the recipients developed aGVHD in group 4, they lost weight
progressively.
16th, 20th,and 50th day,respectively (shown aswhite barsin
Figure 4).
The ratio of donor to recipient PBMCs after semiallo-
geneiclivertransplantation(group2)was1.81% ±0.39%on
the 4th day after transplantation, slightly higher than that of
thegroup1,butthediﬀerencewasnotstatistically signiﬁcant
(P>. 05). Then, the ratio of donor to recipient PBMCs
decreased gradually to 1.03% ± 0.42%, 0.69% ± 0.26%,
0.39% ± 0.29%, and 0.04% ± 0.03%, on the 8th, 16th,
20th, and 50th day, respectively, which were not statistically
diﬀerent from the group 1 (P>. 05) (shown as gray bars in
Figure 4). No donor cells were detected 100 days after liver
transplantation in both groups.
3.4. aGVHD after Liver Transplantation Is Associated with
an Increased Level of Chimerism. In group 4, semiallogeneic
liver transplantation together the with transfusion of 4 ×
108 splenocytes leads to the development of aGVHD in all
recipients. By day 4 after transplantation, the ratio of donor
to recipient PBMCs in these animals was 5.46% ± 2.10%,
signiﬁcantly higher than those of groups 1 and 2 (P<. 05).
Unlikein groups1 and2, thelevelofchimerism inthisgroup
continued to elevate sharply afterwards, reaching 14.12% ±
9.95%,49.79% ± 23.96%,and 69.68% ± 21.97%onthe8th,
12th, and 16th day after transplantation, respectively. These
values (shown as black bars in Figure 4)a r es i g n i ﬁ c a n t l y
higher than those of groups 1 and 2 (P<. 01).
3.5. The Inﬂuence of Splenocyte Transfusion on Chimerism
after Liver Transplantation. The inﬂuence of splenocyte
transfusion on chimerism was studied to conﬁrm that high
levels of chimerism observed in group 4 were correlated
with the onset of aGVHD and not with the number of the
splenocytes. Recipients in group 3 received a transfusion
of 2 × 108 splenocytes, resulting in 50% morbidity due to
aGVHD (6/12 animals). Chimerism increased markedly in
the recipients that developed aGVHD after transplantation4 International Journal of Hepatology
Table 1: Lethality of aGVHD, survival time of each individual animal, and mean survival time (MST) for each group following liver
transplantation.Each transplantationgroup consisted of 6 animals.
Transplantation group Number of donor
splenocytes transferred
Lethality of aGVHD
(fraction of total)
Survival time in days
(number of animals) MST in days
Group 1
(L-L) None 0 >100 (6) >100
Group 2
(L-F1) None 0 >100 (6) >100
Group 3
(L-F1) 2 ×108 50% (3/6) 20 62.5
24
31
>100 (3)
Group 4
(L-F1) 4 ×10
8 100% (6/6) 19 25.3
21
24
26
29
33
Abbreviations: MST: mean survival time; L-L: transplantation from Lewis rat to Lewis rat; L-F1: transplantation from Lewis rat to (LewisxBN)F1 rat.
(a) (b)
Figure 2: Clinical signs and pathological ﬁndings of aGVHD after liver transplantation. (a) In group 2, the appearance of the recipient
returned to normal 2 weeks after transplantation. (b) On the 16th day after liver transplantation, (LewisXBN)F1 recipients in group 4
showed typical clinical signs of aGVHD, including diﬀuse alopecia (especially around the ear, eye, and food), severe athrepsy, hunched
posture, and obvious cachectic.
(shown as blackbars in Figure 5). Conversely, chimerism did
not increase in the recipients without aGVHD, and between
4 and 100 days after the transplantation, the ratio of donor
to recipient PBMCs did not diﬀer signiﬁcantly from that
obs erv edingr oups1an d2(s ho wnaswhit ebar sinFigure 5).
4.Discussion
LTx-aGVHD results from the engraftment of T lymphocytes
associated with the liver graft. However, monitoring the
donor T-lymphocyte chimerism to aid in disease diagnosis
is complicated by the fact that chimerism appears transiently
in the majority of recipients after liver transplantation [19–
21]. We showed that the presence of donorPBMCsincreased
transiently within the ﬁrst several days after syngeneic
liver transplantation and persisted for some time thereafter
in the recipient’s peripheral blood. Thereafter, chimerism
declined rapidly and was usually absent beyond 100 days
after transplantation.
Donor-dominant one-way MHC matching (one-way
matching between a MHC-homozygous donor and a hap-
loidentical recipient) is a recognized risk factor for aGVHD
following liver transplantation [30, 31]. This unidirectional
transplant model allows for studies of the graft-versus-host
reaction without the obscuring eﬀects of a host-versus-graft
reaction that leads to the rejection of donorlymphoid tissues
which often occurs in a fully allogeneic transplant model
[32].
However, even the liver contains large numbers of
lymphoid cells in the parenchyma, the replacement of F1
liver with Lewis liver alone in the semiallogeneic group had
virtually no inﬂuence on the recipient. They all survived
indefinitely and grew in a normal pattern similar to thatInternational Journal of Hepatology 5
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Figure 3: The pathological ﬁndings of aGVHD after liver transplantation. (A1) The histologic examination of skin was normal without
obvious mononuclear inﬁltrating. (A2) Epidermis and dermis of the skin were inﬁltrated by mononuclear cells, and basilar degeneration
and necrosis of keratinocytes were also observed. (B1) The histologic examination of intestine was normal without obvious mononuclear
inﬁltrating. (B2) The intestine contained lymphocytic inﬁltrates. (C1) The histologic examination of liver was normal without obvious
mononuclear inﬁltrating. (C2) No obvious mononuclear inﬁltrate in the liver. (H&E, original magniﬁcation ×400.)
observed in the syngeneic liver transplantation, and there
was no histological evidence of aGVHD. When chimerism
was measured, no signiﬁcant diﬀerence was observed in
compaison with the syngeneic liver transplantation group.
And beyond day 4, the ratio of donor to recipient PBMCs
decreased gradually in both groups. These results indicate
that the fate of donor cells in the recipient’s peripheral blood
was the same after semiallogeneic and syngeneic liver trans-
plantation. It appears that mature donor cells may be elimi-
nated very eﬃcientlywithin daysfollowing arapid migration
into the recipient’s circulation after transplantation.
Inourpreviousstudy, thereproducibleratmodel ofLTx-
aGVHD hasbeen established forthe ﬁrst time by performing
LT from Lewis to (LewisXBN)F1 rat in combination with
donor splenocyte transfusion [23]. And after the transfusion
of 4 × 108 donor splenocytes, simultaneous with liver
transplantation, all recipients developed lethal aGVHD. The
presence of chimerism in the PBMCs increased progressively
after transplantation, and even at an early time (4 days after
transplantation), a signiﬁcant increase in chimerism was
observed. Thus chimerism preceded the ﬁrst clinical signs of
aGVHD, which appeared between 7 and 10 days after liver
transplantation. These results showed that elevated levels
of chimerism are a strong predictor of aGVHD after liver
transplantation, and the detection of chimerism may be of
value in the diagnosis of aGVHD preceding the onset of
clinical symptoms.
To conﬁrm the value of chimerism as a predictor of
aGVHD, it was necessary to rule out the inﬂuence of spleno-
cyte transfusion on chimerism after liver transplantation in
this LTx-aGVHD model. The incidence and morbidity of
aGVHDdependedonthenumberofsplenocytestransferred:
ad o s eo f4× 108 cells gave 100% morbidity, while 2 × 108
cells gave only 50% death (groups 4 and 3, resp., in Table 1).
Chimerism, however, correlated with the onset of aGVHD
and not with the dose of splenocytes, in group 3, chimerism
increased in the recipients that developed aGVHD after liver
transplantation, whereas in the recipients without aGVHD,
no signiﬁcant diﬀerences were observed in comparison with
g r o u p s1a n d2( F i g u r e s1 and 2). These data suggest that
the observed high levels of chimerism in groups 3 and 4
are caused by the aGVH reaction and not dependnt on
splenocyte transfusion number.
Our results showed that the ratio of donor cells to recipi-
ent cells decreased gradually over time and that chimerism
disappeared in group 1 and 2. This phenomenon may be6 International Journal of Hepatology
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Figure 4: Changes of chimerism levels after liver transplantation.
PBMC chimerism following sex-mismatched liver transplantation
was identiﬁed by real-time PCR based on a rat Y-chromosome-
speciﬁc primer, as described in Materials and Methods (Section 2).
As described in Materials and Methods (Section 2), group 1
(white bars) received syngeneic liver transplantation, group 2
(gray bars) received semiallogeneic liver transplantation without
splenocyte transfusion, and group 4 received semiallogeneic liver
transplantationtogetherwith thetransfusionof4×10
8 splenocytes.
Each group consisted of 6 animals. ∗P<. 05, +P<. 01 (compared
with groups 1 and 2).
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Figure 5: association of chimerism with aGVHD. PBMC chimer-
ism following sex-mismatched liver transplantation was identiﬁed
by real-time PCR based on a rat Y-chromosome-speciﬁc primer,
as described in Materials and Methods (Section 2). As described in
MaterialsandMethods(Section 2),group3received semiallogeneic
livertransplantationtogetherwiththetransfusionof2×10
8 spleno-
cytes. Group 3 (aGVHD-), shown as white bars, consisted of 6 ani-
malsthatwerefreefromaGVHD,group3(aGVHD+)consistedof6
animals with aGVHD followingtransplantation ∗P<. 05, +P<. 01.
explained by the induction of a weak immune response
against the male-speciﬁc H-Y antigen after syngeneic sex-
mismatched transplantation, because the male-speciﬁc H-Y
antigen is known to be a minor histocompatibility antigen.
The anti-H-Y immune response has been documented
mainly as cytotoxicity mediated by cytotoxic T lymphocytes
in vitro and by skin graft rejection in vivo [33–35]. In
the nonimmunosuppressed sex-mismatched liver transplant
recipients in our study, an immune response against the
male-speciﬁc H-Y antigen may have caused the disappear-
ance ofdonorcellsfrom thebloodstream without provoking
a host-versus-graft reaction suﬃcient to induce rejection.
Alternatively, the sex-mismatched graft might have induced
mild, self-limiting rejection that recovered spontaneously.
Several studies have demonstrated that the fractionation
of peripheral blood into subpopulations is useful for early
detection of chimerism that may be undetectable in whole
blood even when the percentage of aGVHD eﬀector cells of
donororigin issubstantial [13,16].This fractionation can be
achieved by ﬂuorescent staining followed by ﬂow cytometric
sorting, and large numbers of lymphocyte subpopulations
canbequicklyandeasilyselectedbysequentialimmunomag-
netic beading. However, we did not analyze the chimerism in
subpopulationsof PBMCsin thisstudy. Further experiments
will be necessary to determine the subgroups of PBMCs
responsible for aGVHD after liver transplantation.
In conclusion, we analyzed the change of chimerism
in PBMCs following sex-mismatched liver transplantation
by real-time PCR based on a rat Y-chromosome speciﬁc
primer. And we demonstrated that the high-level chimerism
correlated well with LTx-aGVHD, and the detection of
chimerism soon after transplantation may be of value in the
diagnosis of LTx-aGVHD prior to the onset of symptoms.
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